Jump Financial’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$200K	Sell	3,548 -34,529	-91%	-$2.01M	﹤0.01%	1666
2025 Q4	$2.26M	Sell	38,077 -72,144	-65%	-$3.93M	0.03%	626
2025 Q3	$5.97M	Sell	110,221 -180,996	-62%	-$10.4M	0.08%	356
2025 Q2	$16M	Buy	291,217 +245,017	+530%	+$14.4M	0.2%	134
2025 Q1	$3.27M	Buy	46,200 +41,769	+943%	+$2.81M	0.05%	438
2024 Q4	$291K	Sell	4,431 -15,539	-78%	-$1.04M	0.01%	1317
2024 Q3	$1.4M	Buy	+19,970	New	+$1.67M	0.03%	654
2024 Q2	–	Sell	-3,200	Closed	-$279K	–	1823
2024 Q1	$279K	Buy	3,200 +707	+28%	+$63.3K	0.01%	1481
2023 Q4	$240K	Sell	2,493 -6,366	-72%	-$563K	0.01%	1460
2023 Q3	$784K	Sell	8,859 -60,719	-87%	-$5.4M	0.03%	791
2023 Q2	$6.03M	Buy	+69,578	New	+$6.55M	0.22%	86
2022 Q4	–	Sell	-4,711	Closed	-$400K	–	1588
2022 Q3	$400K	Sell	4,711 -3,365	-42%	-$300K	0.02%	991
2022 Q2	$670K	Sell	8,076 -45,385	-85%	-$3.61M	0.03%	726
2022 Q1	$4.12M	Buy	53,461 +48,813	+1,050%	+$4.08M	0.18%	108
2021 Q4	$411K	Sell	4,648 -16,452	-78%	-$1.36M	0.03%	743
2021 Q3	$1.63M	Buy	+21,100	New	+$1.66M	0.12%	194